Helen J. Ambrose

Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?

Bruce K. Birmingham, Sarah R. Bujac, Robert Elsby et al. · European Journal of Clinical Pharmacology · 2015 · 146 citations

Cardiovascular Disease, Medicine, Genetic Epidemiology +11

Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States

Bruce K. Birmingham, Sarah R. Bujac, Robert Elsby et al. · European Journal of Clinical Pharmacology · 2015 · 136 citations

Translational Medicine, Cardiovascular Disease, Medicine +7

Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial

Benjamin Besse, Elvire Pons‐Tostivint, Keunchil Park et al. · Nature Medicine · 2024 · 102 citations · Full text

Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with <i>AKT1</i> E17K-Mutant, ER-Positive Metastatic Breast Cancer

Lillian M. Smyth, Kenji Tamura, Mafalda Oliveira et al. · Clinical Cancer Research · 2020 · 97 citations · Full text

Genomic Organization of the Mouse Dystrobrevin Gene: Comparative Analysis with the Dystrophin Gene

Helen J. Ambrose, Derek J. Blake, Ralph Nawrotzki et al. · Genomics · 1997 · 39 citations

Developmental Biology, Dystrophin Gene, Genetics +5